Anti-NY-ESO-1 T cell receptor (TCRCD4-NY#7), pCDTCR1(TCR-L161)
The vector of anti-NY-ESO-1 T cell receptor (TCR) is constructed for the engineering of T cell to target Human NY-ESO-1. The T cells are genetically modified through transduction with a lentiviral vector expressing NY-ESO-1-specific T cell receptor. And the vector product was designed for the treatment of Melanoma, breast cancer, lung cancer, prostate cancer, thyroid cancer, ovarian cancer, or synovial cell sarcoma..
Details
Epitope
PVPGVLLKEFTVSGNILTIRLTA
Targeting Diseases
Melanoma, breast cancer, lung cancer, prostate cancer, thyroid cancer, ovarian cancer, or synovial cell sarcoma.
Antibody Clone
TCRCD4-NY#7
Target
Gene Name
cancer/testis antigen 1B
Synonyms
CTAG1B; cancer/testis antigen 1B; CTAG; ESO1; CT6.1; CTAG1; LAGE-2; LAGE2B; NY-ESO-1; NY-ESO-1–positive tumors; scFv; FcεRIγ; Chimeric antigen receptor; T cell; Retrovirus; CARs; Lentivirus; chimeric T cell receptors; chimeric immunoreceptors; chimeric antigen receptors; ES121
Introduction
NY-ESO-1 is a human tumor antigen of the cancer/testis family. It is highly expressed in many poor-prognosis melanomas.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Related Products
Carcinoma
Kits for CARs/TCRs Development